SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar bags ANVISA (Brazil) cGMP approval for Cephalosporin API’s manufacturing facility

15 May 2015 Evaluate

Nectar Lifesciences, the fast-growing manufacturer of generic pharmaceutical active pharmaceutical ingredients (APIs) and formulation products has received ANVISA cGMP (Current Good Manufacturing Practices) approval for Brazil for its Cephalosporin APIs’ manufacturing facility in Dera Bassi, Punjab. The regulatory authority concluded that the facility, systems and practices comply with ANVISA cGMP requirements.

The facility is already approved by various international regulatory agencies such as US-FDA, MCC - South Africa, PMDA-Japan, OGYI-Hungary and KFDA- South Korea.

Brazil market for Cephalosporin’s is currently valued at $300 million between injectable and oral molecules. The company has highest capacities globally of all the approved molecules in Cephalosporin. This approval opens up very valuable market for NecLife for API’s as well as formulations for which Unit-6 located in Baddi is already approved by the ANVISA authority.

Nectar Lifesciences is a leading integrated pharmaceutical organization in India, offering a specialized comprehensive range of oral and sterile cephalosporin active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).



Nectar Lifesciences Share Price

12.66 0.25 (2.01%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×